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The use of Pursed Lips Breathing in stable COPD: a systematic review of the 
evidence 
 
Abstract  
Objective: A systematic review was carried out to determine the evidence for 
teaching pursed lips breathing (PLB) to patients with stable COPD. Exertional 
dyspnoea is the single most important factor limiting function for people with COPD 
and PLB is commonly advocated for its management.  
Method: A literature search of Medline, PEDro and CINAHL Plus was conducted. 
Articles were included if they studied the effects of PLB in stable COPD and 
excluded when proxy interventions or significant modifications of PLB were used. 
Where comparable data were available they were pooled using weighted means. 
Results: Eleven studies involving 226 participants were included; four of the studies 
were of moderate quality according to The Grading of Recommendations 
Assessments, Development and Evaluation (GRADE) system, with the remaining 
studies being of low quality. Although no high quality evidence was identified, with 
the exception of one low quality study, the direction of effect for PLB was 
consistently towards benefit. Moderate quality evidence demonstrates that in stable 
COPD pursed lips breathing increases oxygen saturation and tidal volume, reduces 
respiratory rate during use at rest and reduces time taken to recover to pre-exercise 
breathlessness levels; one RCT showed reduction in exertional dyspnoea and 
improvement in functional performance at 3 months. Additionally, the evidence 
suggests that not all patients with COPD respond equally to PLB, those with moderate 
to severe COPD being most likely to benefit. 
Conclusion: High quality studies are required to identify PLB responders from non-
responders and to determine whether short-term effects translate into clinically 
significant benefit  
 
Keywords: Chronic Obstructive Pulmonary Disease; Dyspnoea; Pursed lips 
breathing; Physiotherapy; Systematic review 
 
 
Introduction 
 
Chronic Obstructive Pulmonary Disease (COPD) is recognised as a major cause of 
morbidity and mortality world wide (1). Nearly 20 years ago COPD was recognised 
as the fifth greatest cause of disability in the world and it has been predicted that it 
will be the third commonest cause of death worldwide by 2020 (2, 3). In 1999 COPD 
accounted for 5% of all deaths in the UK and by 2004 900,000 people, in the UK, had 
a diagnosis of COPD and half as many again were thought to be living with the 
condition undiagnosed (4).  The most frequent and disabling complaint of people with 
COPD is exertional breathlessness; this is often the primary reason people with COPD 
seek medical help. Exertional breathlessness, also referred to as exertional dyspnoea 
is breathlessness triggered by physical exertion where the degree of breathlessness 
reported is disproportionate to the physical exertion undertaken (5). Exertional 
dyspnoea is the single most important factor limiting function on a day-to-day basis 
with progression of COPD being associated with increasing exertional dyspnoea, 
which may extend to dyspnoea at rest, and worsening quality of life (2, 6, 7).  
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Pursed lips breathing (PLB) is a breathing retraining strategy, adopted spontaneously 
by some patients, that has also been advocated for the treatment of dyspnoea (5). It is 
customarily integrated into pulmonary rehabilitation programmes for the management 
of exertional dyspnoea in COPD (8-10).  PLB is carried out by exhaling through 
partially closed lips i.e. through pursed lips as if making the flame of a small candle 
flicker. It has also been described as “moderately active expiration through half 
opened lips” with reported mean expiratory mouth pressures of 5 cmH2O being 
generated (11). 
 
The role of PLB however is not without controversy; it is reported as possibly 
reducing the discomfort associated with dyspnoea, either through alteration in the 
breathing pattern and gaseous exchange or by subjective means but also labelled as a 
dysfunctional breathing pattern(12, 13). With this in mind the literature for PLB was 
reviewed to ascertain the quality of evidence, indications, and effects of PLB when 
used in the management of patients with stable COPD. The Grading of 
Recommendations Assessments, Development and Evaluation (GRADE) system 
followed assesses both the quality of evidence and the balance of benefits and harms. 
It has been adopted by a number of national and international organisations including 
the World Health Organisation, the American Thoracic Society and the Cochrane 
Collaboration among others (14-17). The GRADE system classifies quality of 
evidence as High, Moderate, Low or Very Low with the option to amalgamate the last 
two categories. High quality evidence is defined as being such that “further research is 
very unlikely to change our confidence in the estimate of effect”, moderate quality 
evidence as “further research is likely to have an important impact on our confidence 
in the estimate of effect and may change the estimate” and low quality evidence as 
“further research is very likely to have an important impact on our confidence in the 
estimate of effect and is likely to change the estimate” (16). 
 
 
Methods 
Literature Search: The databases Medline, PEDro and CINAHL Plus were searched 
for English language papers containing “pursed lip breathing” and “pursed lips 
breathing” in the title or abstract. Search criteria excluded children and animal studies. 
Studies were also excluded from further consideration if they were performed on 
healthy volunteers, did not have stable COPD as the patient population, used proxy 
interventions or significant modifications of PLB, or were not original research. The 
papers cited as references in each paper were also identified for relevance. The proxy 
interventions and modified PLB identified and excluded were the use of expiratory 
resistive loading to mimic PLB and manual assistance in addition to PLB. 
 
Assessment of Published Studies: Studies identified were assessed using the 
Grading of Recommendations Assessments, Development and Evaluation (GRADE) 
system (14-17). Initially an explicit statement of the question to be addressed was 
framed: “What is the effect of teaching pursed lips breathing to patients with stable 
COPD?” and then the papers identified in the literature search were reviewed firstly 
for relevance in answering this question and then with regard to study design and 
methodology. In particular, method of allocation to groups, blinding, loss to follow-up 
and power to detect effect, using National Institute of Health and Clinical Excellence 
(18) taxonomy and methodology checklists were considered. The studies providing 
the highest quality evidence were looked at in detail and results of lower quality 
studies looked at to assess consistency of effect. 
 
Where comparable data were available they were pooled using weighted means. The 
weighted mean was used in order to combine mean values from comparable studies 
with different sample sizes but still represent all the individual scores equally. The 
weighted mean was derived by multiplying the mean of each study by its sample size, 
summing these, then divided by the total number of participants in all studies.  
 
Finally a summary of findings based on the evidence, including the balance of 
desirable and undesirable effects, likely variability of patient response and the extent 
to which the intervention represents a good use of resources was made. 
 
Results 
Available Literature: The initial database search identified 54 papers. PLB is 
variously lengthened as pursed lips, pursed-lips, pursed lip and pursed-lips breathing; 
searching on pursed lips breathing returned the most complete results. Following 
exclusion of studies identified by more than one search engine nine were relevant (19-
27) and two further studies were identified from the reference list of these nine studies 
(28, 29).  
 
Study design: All 11 studies were prospective studies with subjects chosen to 
participate in a planned trial with identified outcome measures in order to answer a 
pre-specified research question or hypothesis. Ten studies addressed the short-term 
effects of PLB. The remaining study (25) looked at the effects of PLB over 12 weeks. 
All studies made a comparison between groups; two were randomised controlled trials 
(25, 27), the remainder compared different interventions to the same group of patients 
over time. 
 
Quality of Literature: None of the 11 studies identified fulfilled all the stated criteria 
for a high quality study with regard to randomisation, blinding to allocation, 
comparison with control group or sufficient trial size to ensure power to detect effect 
however four studies of moderate quality were identified (22, 23, 25, 27); the 
remaining studies were of low quality. Table 1 summarises these findings. 
 
Effects of PLB on oximetry, tidal volume and respiratory rate at rest: PLB, used 
at rest in subjects with stable COPD, has positive short-term effects on oximetry, tidal 
volume and respiratory rate. Four studies reported on the effects of PLB on oximetry 
seven on tidal volume and nine on respiratory rate, with at least one of the studies in 
each case being of moderate quality. Not all the studies reported gave raw data and 
therefore range or standard deviation could not be calculated however results reported 
here were statistically significant. Two studies (28, 29) accounting for 19 subjects (7 
and 12 respectively) gave results significant to p < 0.5 with the remaining studies 
having a significane of at least < 0.05.  
 
Training with oximetry feedback resulted in a mean increase in oxygen saturation of 
4.5%, from a baseline of 91.1%, a mean increase in tidal volume of 0.600 millilitres 
and a mean reduction in respiratory rate of 7.2 breaths per minute (27). Pooling the 
comparable data from all available studies resulted in similar findings: a reduction in 
respiratory rate of 6.6 breaths per minute, an increase in tidal volume of 500 millilitres 
and an increase in oxygen saturation of 2.5%. Table 2 summarises these findings. 
 
Effects on respiratory rate and tidal volume on exercise: Only one study, of 
moderate quality, reported on the effects of PLB used by subjects with stable COPD 
during maximal exercise and in the recovery period after exercise. This study 
demonstrated beneficial short-term effects on recovery time (22). PLB used during the 
incremental shuttle walk test (ISWT) and during the recovery period resulted in a 
mean reduction in end exercise respiratory rate of 6.2 (95%`confidence intervals 4.5 – 
7.9) breaths per minute and a mean reduction in recovery time of 25 (95%`confidence 
intervals 2.8 – 47) seconds, that is 12%. There was no change in ISWT distance (22). 
 
Two low quality studies (24, 26) considered the effects of PLB on respiratory pattern 
during sub-maximal exercise protocols and showed a reduction in respiratory rate and 
an increase in tidal volume. Both of these studies provided sufficient raw data to show 
the range of subject response; this was considerable. Reduction in respiratory rate 
using PLB varied from 0 to 20 breaths per minute and increase in tidal volume from –
10 millilitres to + 996 millilitres. These findings are summarised in Table 3.  
 
Effects on work of breathing: PLB has been shown to cause a shift in inspiratory 
muscle work from the diaphragm to the intercostal muscles when compared to resting 
breathing (28). Compared to resting breathing, one study of moderate quality showed 
PLB is associated with lower oxygen consumption (23) and a further, low quality 
study showed statistically significant improvement in arterial blood gases despite 
reduced minute ventilation: reduction in PaCO2 of 0.59 kPa and increase in PaO2 of 
0.43 kPa (24).  
 
Effects on dyspnoea: The impact of PLB on dyspnoea remains uncertain. Five 
studies identified consider the impact of PLB on dyspnoea. Breathlessness was 
measured in a variety of ways with Borg perceived breathlessness scale (30) being the 
most frequently used outcome measure. All studies investigated dyspnoea 
experienced by populations of stable COPD subjects either during every day activities 
or during specific periods of exercise and as such can be said to relate to exertional 
dyspnoea. Of these five studies only one was of moderate quality. From the pooled 
data 40% of COPD subjects can be predicted to report relief from dyspnoea using 
PLB in these circumstances. This is summarised in Table 4. Relief from dyspnoea 
when using PLB correlates most strongly with the ability of PLB to reduce end-
expiratory lung volumes (19, 26). From the individual studies, use of PLB was 
variously shown to result in: a 12% reduction in recovery time from dyspnoea after 
maximal exercise as measured by Borg perceived breathlessness scale and respiratory 
rate in 48 subjects (22), self-reported relief of dyspnoea in 7 out of 12 subjects (24), 
reduction in breathlessness in 19 the out of 30 subjects as measured by Borg 
perceived breathlessness scale (19), a worsening in 4, no change in 2 and 
improvement in 2 of 8 subjects for breathlessness as measured by visual analogue 
scale during sub-maximal exercise (26), no change in breathlessness at rest as 
measured by Borg perceived breathlessness scale in 12 subjects (28). 
 
Recently optoelectronic plethysmography has been used to evaluate changes in chest 
wall compartment volumes, to assess whether the volume changes of the chest wall 
can help identify the reason why some patients benefit from PLB and others do not. 
Thirty patients with COPD were studied and two distinct patterns of breathing that 
were adopted when instructed to use PLB were identified (19). The 19 most severely 
obstructed and hyperinflated patients increased their tidal volume (mean 630mls) by 
decreasing the end-expiratory volumes of the chest wall and abdomen. The remaining 
11 patients increased their tidal volume (mean 360mls) but this was associated with 
an increase in end-expiratory volume i.e. overall hyperinflation. Whilst the first group 
reported a reduction in breathlessness using PLB the second group did not. The 
subjects that demonstrated no worsening hyperinflation and a mean reduction in Borg 
score using PLB had a mean FEV1 % predicted of 38% +/- 13 i.e. moderate to severe 
COPD (31). The subjects that demonstrated worsening hyperinflation and no mean 
change in Borg score using PLB had a mean FEV1% predicted of 56% +/- 14 i.e. 
mild COPD. 
 
Medium-term effects: A 4-week PLB teaching programme resulted in reduced 
breathlessness on 6-minute walk test and improved health related quality of life at 12 
weeks (25). The randomised controlled 3-limb study compared a 4-week intervention 
of PLB, expiratory muscle training or education (control) in 40 subjects with stable 
COPD. Significant improvement was only shown in the PLB limb, with a mean 
reduction of 0.9 in Borg scores at the end of 6 minute walk and mean increases in SF-
36 physical function domain of 16.  
 
Method of teaching PLB: Studies vary in the detail given regarding teaching PLB 
with seven of the studies reviewed giving some details. Where detail is provided these 
have been summarised in Table 5. Of particular note the inspiratory to expiratory ratio 
encouraged can be seen to vary considerably from 1:2 to 1:4 or more and the use of 
oximetry biofeedback is detailed in only 2 studies (25, 27). 
 
Direction of effect: Despite evidence from any trial fulfilling all the stated criteria for 
a high quality study the direction of effect towards benefit from PLB, with the 
exception of one study (26), was consistent. 
 
Discussion 
 
Review of the literature and application of the GRADE system to studies of the 
effects of PLB in stable COPD suggests that PLB is safe and that there is moderate 
quality evidence to support its use in clinical practice.  
 
Study design: The main concerns with regard to study design were insufficient power 
to draw sustainable conclusions, poor randomisation and lack of blinding. For PLB, 
blinding of participants and those delivering the intervention is not possible however 
those assessing and analysing the outcome could have been blinded to allocation. This 
is a pre-requisite for a high quality randomised controlled trial.  
 
Effects on dyspnoea: The stated purpose of teaching PLB is the relief of dyspnoea 
however the impact on this symptom remains the most uncertain. As reported in the 
results all studies reviewed for this paper that reported directly on dyspnoea were 
investigating the impact of PLB on exertional dyspnoea in stable COPD. The 1970’s 
study by Mueller et al (24) reported 7 of 12 subjects gaining relief from dyspnoea 
when using PLB and highlights the observation in clinical practice that, whilst some 
patients report considerable benefit from PLB, others do not. In 2007, for the first 
time, the work by Bianchi et al (19) demonstrated clear differences between PLB 
responders and non-responders. Benefit from PLB was demonstrated only in those 
with moderate to severe COPD. From the data presented here 40% of COPD subjects 
can be predicted to benefit from PLB but this is an amalgamation of response rates 
varying from zero to 63% and may reflect the varying severity of COPD in subjects 
studied.  
 
These two sub-groups of COPD patients, the PLB responders and non-responders, 
would appear to be a strong confounding factor in trials to date with non-responders 
reducing the power to detect benefit in responders.  
 
Teaching PLB in clinical practice: Another possible explanation for the wide 
variation in PLB response rate may be variation in methods for teaching PLB. The 
logistics and resources required in clinical practice remain inconclusive with 
variations in reported practice, or practice not fully described. The most effective 
means of teaching PLB and the need for oximetry feedback during learning has not 
yet been established, neither has the extent and number of follow up visits required to 
establish effective PLB in the clinical setting and to achieve effective carry over into 
daily life. 
 
Clinical Significance of findings: Regardless of statistical significance, having 
identified that PLB provides the possibility of reducing respiratory rate by nearly 7 
breaths per minute, increasing tidal volumes by 500mls and improving oxygen 
saturations by 2.5% these clinically significant changes might be expected to result in 
appreciable day-to-day benefit for patients and this is supported by an improved 
recovery rate from exercise induced breathlessness (22). When these short-term 
benefits are experienced over a longer period in everyday life this may then translate 
into longer-term benefits in the form of improved functional performance. The 
improvement in SF-36 Physical Functioning scale of 16 points reported by Nield et al 
(25) is likely to be clinically significant; 23 points has been reported as the impact of a 
chronic medical condition on everyday physical function (32) and 10.5 as a change 
recognized by the general population as indicating “much better” (33).  
 
Conclusion 
 
The evidence to date suggests that for a sub-group of patients with stable COPD, PLB 
has 3 areas of effects: during use at rest PLB training with oximetry biofeedback 
increases oxygen saturation and tidal volume whilst reducing respiratory rate; when 
used during exercise and in the recovery period after exercises it reduces the recovery 
time of breathlessness; when taught over 4 weeks, PLB reduces exertional dyspnoea 
and improves functional performance as measured at 3 month follow-up. 
 
Based primarily on the 3 clinical studies of best quality evidence (22, 25, 27) it would 
be reasonable to attempt to teach PLB using oximetry biofeedback to stable COPD 
patients within existing care delivery programmes such as pulmonary rehabilitation 
programmes. Respiratory rate and oxygen saturations should be recorded during quiet 
breathing and during PLB at rest with advice given to the patient dependent on the 
observed response.  Where respiratory rate falls and oxygen saturation increases with 
PLB the patient should be advised to practise PLB at rest on a daily basis and to try 
using it during activities that normally make them breathless or to speed their 
recovery when they have become breathless. Where no positive response is observed 
it should be explained to the patient that this is a technique that seems to help some 
patients more than others and they may or may not benefit from it. Daily practise, as 
before, for 4 weeks can be trialled with a low threshold for discontinuing use if no 
benefit is seen. 
 
Whilst this review has demonstrated there is reason to expect PLB to have a role in 
the symptomatic management of stable COPD further high quality studies are 
required to determine how to stratify patients into PLB responder and non-responders 
both for research purposes and for clinical practice. In addition the focus of future 
research should aim to replicate medium term effects and identify long-term effects of 
PLB in clinical practice including using outcome measures to capture benefit in 
dyspnoea, exercise endurance and health related quality of life outcomes. 
Table 1: Design and methodological features for PLB studies reviewed 
 
Reported  
Comparison  Randomisation Blinding Power Ref 
Control 
group 
  x   (25)* 
    x (27)* 
Same 
Group 
over time 
      (22)* 
  x   (22, 23)* 
  x x (19, 24, 26) 
x x x (20, 21, 28, 
29) 
* Studies assessed as moderate quality according to GRADE system definitions 
Table 2: Effects of PLB in stable COPD, used at rest 
 
 No of 
studies 
Total 
number of 
subjects 
Weighted 
mean 
Refs 
Respiratory 
rate  
9 138 -6.6 bpm (19-21, 23, 24, 26-
29) 
Tidal Volume  7 103 +500mls (19, 20, 24, 26-29) 
Oxygen 
saturation* 
4 49 +2.5% (21, 24, 27, 28) 
*Measured by finger or ear oximetry in all except one study (24) where arterial blood 
gases were used 
Table 3: Effect of PLB in stable COPD, used during exercise  
 
 No of 
studies 
Total 
number of 
subjects  
Weighted mean Refs 
RR on sub-
maximal ex 
2 19 -6.98 bpm 
(range 0 to -20 bpm) 
(24, 26) 
TV on sub-
maximal ex 
2 19 +270mls 
(range –10 to 996mls) 
(24, 26) 
RR – respiratory rate, bpm - breaths per minute, TV - tidal volume, mls - millilitres, 
ex - exercise
Table 4: Proportion of COPD patients reporting benefit from PLB  
 
% PLB responders 
(weighted mean) 
Total number 
of subjects 
Refs 
40% responders  
Range 0 – 63% 
110 (19, 22, 24, 26, 28) 
 
Table 5: Information provided from seven studies on PLB technique and application 
 
PLB instructions “Normal” breath in through nose, out through pursed lips 
avoiding forceful exhalation, or similar (19-22, 25-27) 
Breath out for twice as long as breath in (27) 
Breath out for as long as you comfortably can (25) 
Breath out 3 to 4 times as long as breath in (22) 
Additional 
information  
4 hospital visits and diary system to record practice. Practice 
10 min/day for the first week increasing to 25 min/day in 
frequent short practices by the fourth week (25) 
Co-ordinate walking and breathing so that you breathe in for 
one stride and out for 2 (25) 
Whilst learning subjects instructed to observe oximeter with 
aim of increasing saturations(25, 27)  
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Comments from the Editors and Reviewers – response 
The use of Pursed Lips Breathing in stable COPD: a systematic review of the 
evidence 
Reviewer #1: The concept of the systematic review is a good one and will be of great 
interest to physiotherapists working with the population with COPD. 
There are some features of the review that should be adapted in order to improve its 
accuracy: 
 
Title, abstract and text 
The author uses the term "Pursed Lips Breathing" - whereas literature commonly 
referred to used the term "pursed lip breathed" or "pursed-lip breathing". No capitals 
are required and it is recommended that the author applies one of the two more 
commonly used phrases throughout the manuscript. 
RESPONSE: I chose pursed lips breathing as my impression from the literature was 
that this was the more internationally used term although in clinical practice 
(England) my colleagues and I use pursed lip breathing. From a review of the search 
terms pursed lips breathing returns the most complete search results and therefore I 
would prefer to continue with pursed lips breathing.  
 
Introduction 
Paragraph 1- the author should revise the reference and statement referring to 
developed countries to include all countries. WHO data clearly state that COPD is a 
health priority in all countries. The references used in the next section (2 & 3) refer to 
data from 1997 and 1998 and should be updated to reflect the most recent 
prevalence statistics. 
 
RESPONSE: Regarding developed countries/all countries I agree with the comment 
and have changed the sentence. Regarding prevalence data the reviewer is correct 
that the prevalence data comes from 97/98; I searched the WHO data carefully and 
could not find more recent worldwide prevalence data but the following sentences 
bring the data more up to with the aim of showing this continues to be a significant 
problem. 
 
The author should describe what they mean by the term dyspnoea - it is not clear 
whether they are using it synonymously with "exertional dyspnoea" but if so that is 
technically incorrect. 
RESPONSE: defined in intro and specified in results on dyspnoea 
 
In paragraph 2 the author quotes a description of the PLB technique (ref 11) but 
does not  quote a page reference. 
RESPONSE: Ref 11 is a journal ref and includes pgs 29-34  but as outlined below 
was an incomplete reference that has now been updated 
*Response to reviewer comments
 
In paragraph 3 refs 12 and 13 are texts but there is no link to chapters in the texts. 
RESPONSE: ref 12 is not a multi-authored book therefore referencing had followed 
advice to contributors however I have now added the relevant page number as for 
multi-authored book. Ref 13 is a multi-authored book so have amended the 
reference accordingly 
 
The GRADE system is described in this paragraph and again in paragraphs 2 & 3 of 
the method - . it would be better to include the details of the ranges here and delete 
the description in the methods section. 
 
RESPONSE: changed as suggested 
 
Methods 
Paragraph 3 - data are plural 
RESPONSE: agree, changed as suggested 
Results 
Paragraph 1 - write numbers <10. 
RESPONSE: agree, changed as suggested 
 
Paragraph 3. The findings are summarised in Table 1." 
It would be helpful if each of the sections that follow is introduced in a standardised 
way indicating the number of papers included and the level of evidence 
RESPONSE: I have tried to address the points made here without making the text 
un-necessarily cumbersome. Information on number of papers studied included. 
 
Paragraph 4 It is not clear from the text how many studies were included here. 
Paragraph 5 It is not clear from the text how many studies were included here. 
RESPONSE: Inclusions to Para’s 4 and 5 made to address above points 
  
Paragraph 6 There are a few changes in wording required to improve accuracy e.g. 
PLB does not generate changes in pleural pressure. 
RESPONSE: Attempt to clarify meaning of sentence on pleural pressure by focusing 
on implication 
 
Paragraph 7 - Suggest using the term pooled rather than amalgamated. In this 
section is the author referring to the weighted mean. Reference the Borg scale as 
well as the manuscripts under discussion. 
RESPONSE: both points addressed 
 
Paragraph 8 Correct the format of the Bianchi reference; Clarify the reference to 
FEV1 of 38% being moderate to severe COPD  
RESPONSE: Bianchi ref corrected, reference to COPD severity included  
 
Discussion 
The discussion should start with an overarching paragraph about the outcomes of 
the systematic review. The conclusion includes some statements that could be used 
earlier in the discussion 
RESPONSE: intro to discussion included 
 
Are there any other factors to be discussed that may influence whether subjects are 
responders and non responders besides severity of respiratory function e.g. airway 
pathology? 
RESPONSE: based on evidence reviewed it is not possible to draw other 
conclusions 
 
Table 1 - title - it is only the studies included not all the ones that were identified that 
are referred to in the table 
RESPONSE: corrected 
 
Table 2 was the arterial oxygen saturation peripheral? 
RESPONSE: predominantly peripheral oximetry – note to table added 
In light of comment below I have included sentence on statistical significance (not all 
papers give raw data therefore could not analyse further) 
 
Table 3 spell out the words in the table or else have a code underneath it what were 
the standard deviations and ranges? 
RESPONSE: code included, however does feel a bit like stating the obvious. Raw 
data was given in these two papers so I have included ranges 
Table 4 include number of studies in the title; what was the standard deviation? 
RESPONSE: Inclusion of references identifies that this relates to 5 studies. I do not 
think clarity would be improved by adding “in 5 studies” to title; but can do if felt 
essential. Standard deviation – the variation of measures used, as indicated in the 
text, means it would not be appropriate to try to identify standard deviation hence the 
decision to include range of response reported by the different studies to indicate this 
is a very variable outcome 
 
Table 5 change practise to practice; suggest layout change to more clearly identify 
the number of studies referenced. 
RESPONSE: my understanding was when practice/practise refers to an activity e.g. 
practising swimming or in this case practising PLB the correct spelling was with an 
“s” and so have left it as “s” but happy to be guided by editor. Spelt with a “c” when 
referring to clinical practice. Number of studies included in title.  
 
References 
There are a number of errors in the list e.g. some journals are abbreviated and 
others not; no chapter references with texts; no contract or document numbers for 
reference 17; incomplete referencing 11, need to spell out come abbreviations e.g. 
ATS 
Indicate what the asterisk refers to as it is not coded anywhere. 
RESPONSE: Referencing errors corrected. Regarding asterisk: from notes for 
contributors “Please indicate the 3-10 most important references clearly (e.g. by an 
asterisk).” I assumed the journal format would therefore indicate the reason for 
asterisks but have added a line at the beginning of the references in case not. 
